IN2013MU02726A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02726A
IN2013MU02726A IN2726MU2013A IN2013MU02726A IN 2013MU02726 A IN2013MU02726 A IN 2013MU02726A IN 2726MU2013 A IN2726MU2013 A IN 2726MU2013A IN 2013MU02726 A IN2013MU02726 A IN 2013MU02726A
Authority
IN
India
Prior art keywords
purification
parathyroid hormone
steps
rhpth1
teriparatide
Prior art date
Application number
Other languages
English (en)
Inventor
Mendiratta Sanjeevkumar
Singh Avanishkumar
Bandyopadhyay Sanjay
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CA2919604A priority Critical patent/CA2919604A1/fr
Priority to PCT/IN2014/000539 priority patent/WO2015025335A1/fr
Priority to NZ716205A priority patent/NZ716205A/en
Priority to CN201480046603.3A priority patent/CN105473610A/zh
Priority to MX2016002274A priority patent/MX2016002274A/es
Priority to EP14793628.0A priority patent/EP3036252A1/fr
Priority to AU2014310255A priority patent/AU2014310255B2/en
Priority to KR1020167003963A priority patent/KR101687686B1/ko
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Priority to SG11201600511QA priority patent/SG11201600511QA/en
Priority to US14/912,984 priority patent/US20160200792A1/en
Priority to JP2016516093A priority patent/JP6046862B2/ja
Priority to IN2726MU2013 priority patent/IN2013MU02726A/en
Priority to EA201690264A priority patent/EA201690264A1/ru
Publication of IN2013MU02726A publication Critical patent/IN2013MU02726A/en
Priority to IL243642A priority patent/IL243642A/en
Priority to ZA2016/00424A priority patent/ZA201600424B/en
Priority to HK16111539.7A priority patent/HK1223378A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/635Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361Ion-exchange
    • B01D15/363Anion-exchange
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
IN2726MU2013 2013-08-21 2014-08-21 IN2013MU02726A (fr)

Priority Applications (16)

Application Number Priority Date Filing Date Title
SG11201600511QA SG11201600511QA (en) 2013-08-21 2014-08-21 Purification process for pth
PCT/IN2014/000539 WO2015025335A1 (fr) 2013-08-21 2014-08-21 Procédé de purification de pth
US14/912,984 US20160200792A1 (en) 2013-08-21 2014-08-21 Purification Process for PTH
MX2016002274A MX2016002274A (es) 2013-08-21 2014-08-21 Procedimiento de purificacion para la hormona paratiroidea recombinante.
EP14793628.0A EP3036252A1 (fr) 2013-08-21 2014-08-21 Procédé de purification de pth
AU2014310255A AU2014310255B2 (en) 2013-08-21 2014-08-21 Purification process for PTH
KR1020167003963A KR101687686B1 (ko) 2013-08-21 2014-08-21 Pth를 정제하는 방법
CA2919604A CA2919604A1 (fr) 2013-08-21 2014-08-21 Procede de purification de pth
NZ716205A NZ716205A (en) 2013-08-21 2014-08-21 Purification process for pth
CN201480046603.3A CN105473610A (zh) 2013-08-21 2014-08-21 用于pth的纯化方法
JP2016516093A JP6046862B2 (ja) 2013-08-21 2014-08-21 Pthの精製方法
IN2726MU2013 IN2013MU02726A (fr) 2013-08-21 2014-08-21
EA201690264A EA201690264A1 (ru) 2013-08-21 2014-08-21 Способ очистки pth
IL243642A IL243642A (en) 2013-08-21 2016-01-17 Parathyroid hormone purification process
ZA2016/00424A ZA201600424B (en) 2013-08-21 2016-01-19 Purification process for pth
HK16111539.7A HK1223378A1 (zh) 2013-08-21 2016-10-04 用於 的純化方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2726MU2013 IN2013MU02726A (fr) 2013-08-21 2014-08-21

Publications (1)

Publication Number Publication Date
IN2013MU02726A true IN2013MU02726A (fr) 2015-06-26

Family

ID=51862491

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2726MU2013 IN2013MU02726A (fr) 2013-08-21 2014-08-21

Country Status (16)

Country Link
US (1) US20160200792A1 (fr)
EP (1) EP3036252A1 (fr)
JP (1) JP6046862B2 (fr)
KR (1) KR101687686B1 (fr)
CN (1) CN105473610A (fr)
AU (1) AU2014310255B2 (fr)
CA (1) CA2919604A1 (fr)
EA (1) EA201690264A1 (fr)
HK (1) HK1223378A1 (fr)
IL (1) IL243642A (fr)
IN (1) IN2013MU02726A (fr)
MX (1) MX2016002274A (fr)
NZ (1) NZ716205A (fr)
SG (1) SG11201600511QA (fr)
WO (1) WO2015025335A1 (fr)
ZA (1) ZA201600424B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3012952B1 (fr) * 2013-11-08 2015-11-06 Essilor Int Methode de determination d'au moins un parametre de conception optique d'une lentille ophtalmique progressive
WO2019077432A1 (fr) * 2017-10-16 2019-04-25 Intas Pharmaceuticals Ltd. Procédé de purification amélioré de pth (1-34) de recombinaison
CN107941983B (zh) * 2018-01-05 2020-05-15 北京博康健基因科技有限公司 一种rhPTH蛋白或rhPTH蛋白制剂的检测方法和纯度的分析方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0273928B1 (fr) * 1986-07-18 1997-01-08 The University Of Melbourne Proteine active lors d'hypercalcemie humorale liee a des tumeurs malignes (pthrp)
US5171670A (en) * 1989-05-12 1992-12-15 The General Hospital Corporation Recombinant dna method for production of parathyroid hormone
DE3935738A1 (de) * 1989-10-27 1991-05-08 Forssmann Wolf Georg Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff
ATE185146T1 (de) * 1996-06-14 1999-10-15 Takeda Chemical Industries Ltd Verfahren zur entfernung von n-terminalem methionin
AU7701398A (en) * 1997-05-30 1998-12-30 Bion, Inc. Large-scale isolation and purification of hif
JP4319979B2 (ja) * 2002-04-26 2009-08-26 ジェネンテック・インコーポレーテッド タンパク質の非アフィニティ精製
EP1598075A1 (fr) * 2004-05-21 2005-11-23 LEK Pharmaceuticals d.d. Procédé pour l'isolement et/ou la purification de protéines
CN1706947A (zh) * 2004-06-04 2005-12-14 南京大学生物制药工程研究中心 重组人甲状旁腺激素在大肠杆菌中的构建、表达与纯化方法
US7585943B2 (en) * 2005-04-20 2009-09-08 Viromed Co., Ltd. Compositions and methods for fusion protein separation
CN1861790A (zh) * 2006-04-25 2006-11-15 华东理工大学 重组人甲状旁腺激素1-84的制备方法
EP2173768B1 (fr) * 2007-08-09 2014-03-05 USV Limited Nouveau procédé orthogonal pour la purification de l'hormone parathyroïdienne humaine recombinante (rhpth) (1-34)
US8853380B2 (en) * 2010-06-04 2014-10-07 Lupin Limited Modified SAK gene for the production of recombinant proteins
US20120264920A1 (en) * 2010-10-11 2012-10-18 Abbott Laboratories Processes for purification of proteins

Also Published As

Publication number Publication date
KR20160027204A (ko) 2016-03-09
IL243642A (en) 2017-05-29
JP6046862B2 (ja) 2016-12-21
KR101687686B1 (ko) 2016-12-19
AU2014310255B2 (en) 2017-02-16
EP3036252A1 (fr) 2016-06-29
JP2016528173A (ja) 2016-09-15
CA2919604A1 (fr) 2015-02-26
AU2014310255A1 (en) 2016-02-25
MX2016002274A (es) 2016-05-31
ZA201600424B (en) 2017-03-29
WO2015025335A1 (fr) 2015-02-26
WO2015025335A8 (fr) 2016-02-04
US20160200792A1 (en) 2016-07-14
HK1223378A1 (zh) 2017-07-28
SG11201600511QA (en) 2016-02-26
EA201690264A1 (ru) 2016-06-30
NZ716205A (en) 2017-05-26
CN105473610A (zh) 2016-04-06
IL243642A0 (en) 2016-03-31

Similar Documents

Publication Publication Date Title
MX2019011759A (es) Composicion para producir tagatosa y procedimiento de produccion de tagatosa usando el mismo.
BR112018077067A2 (pt) processo para preparar um composto.
EP3708660A3 (fr) Polypeptides
MY181068A (en) Recombinant microorganism for improved production of fine chemicals
SA515361251B1 (ar) طريقة لزيادة تكوين حمض بيرو-جلوتاميك من بروتين
PH12016501094A1 (en) Recombinant microorganism for improved production of fine chemicals
PH12017502240A1 (en) Recombinant microorganism for improved production of alanine
MX368142B (es) Metodo de clonacion, expresion y purificacion novedoso para la preparacion de ranibizumab.
PH12017502215A1 (en) Recombinant microorganism for improve production of fine chemicals
MX2016007297A (es) Proceso para purificar 2,5-diclorofenol.
MX2019011758A (es) Composicion para producir tagatosa y procedimiento de produccion de tagatosa usando la misma.
IN2015KN00323A (fr)
MY172080A (en) Microorganisms having putrescine productivity and process for producing putrescine using the same
PH12018500150A1 (en) Microorganisms for producing putrescine or ornithine and process for producing putrescine or ornithine using them
SG11201803147QA (en) Method for purifying organic solvent
CA2862820A1 (fr) Clivage enzymatique sur colonne
MY176584A (en) Gluconate repressor variant, microorganism containing the same producing l-lysine, and method for producing l-lysine
MX2016001220A (es) Procedimiento para preparar un componente neurotoxico altamente puro de una toxina botulinica y usos del mismo.
MY187692A (en) Distillation system for reducing energy consumption by thermal coupling
IN2013MU02726A (fr)
MX2020000433A (es) Metodo para recuperar acido fosforico del lecho de residuos de fermentacion o residuos de fermentacion y reutilizacion del mismo.
MX2016001720A (es) Coloides metalicos modificados en superficie y produccion de los mismos.
MX2019006783A (es) Procedimiento para la preparacion de 4-amino-1-( (1s, 4r, 5s) -2-fluoro-4,5-dihidroxi-3-hidroximetil-ciclopent-2-enil)-1h-pirim idin-2-ona.
MX2013006879A (es) Metodo para producir un par de miembros de limpiaparabrisas.
MX364769B (es) Proceso para producir 2-fenil-1, 3-benzoxazoles.